To include your compound in the COVID-19 Resource Center, submit it here.
Several companies are looking for therapeutic combinations that change how oncolytic viruses interact with cancer cells.
At least two companies, Oncolys BioPharma Inc. and Oryx GmbH & Co. KG, are
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury